Gene Review:
Cd55 - CD55 antigen
Mus musculus
Synonyms:
Cd55a, Complement decay-accelerating factor, GPI-anchored, Cromer blood group, DAF-GPI, Daf, ...
- The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. Liu, J., Miwa, T., Hilliard, B., Chen, Y., Lambris, J.D., Wells, A.D., Song, W.C. J. Exp. Med. (2005)
- Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis. Lin, F., Salant, D.J., Meyerson, H., Emancipator, S., Morgan, B.P., Medof, M.E. J. Immunol. (2004)
- Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease. Lin, F., Spencer, D., Hatala, D.A., Levine, A.D., Medof, M.E. J. Immunol. (2004)
- Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Lublin, D.M., Mallinson, G., Poole, J., Reid, M.E., Thompson, E.S., Ferdman, B.R., Telen, M.J., Anstee, D.J., Tanner, M.J. Blood (1994)
- Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor sp1. Cauvi, D.M., Cauvi, G., Pollard, K.M. J. Immunol. (2006)
- Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity. Miwa, T., Sun, X., Ohta, R., Okada, N., Harris, C.L., Morgan, B.P., Song, W.C. Immunology (2001)
- Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis. Lin, F., Emancipator, S.N., Salant, D.J., Medof, M.E. Lab. Invest. (2002)
- Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Lin, F., Fukuoka, Y., Spicer, A., Ohta, R., Okada, N., Harris, C.L., Emancipator, S.N., Medof, M.E. Immunology (2001)
- Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form. Song, W.C., Deng, C., Raszmann, K., Moore, R., Newbold, R., McLachlan, J.A., Negishi, M. J. Immunol. (1996)
- Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection. Lin, F., Kaminski, H.J., Conti-Fine, B.M., Wang, W., Richmonds, C., Medof, M.E. J. Clin. Invest. (2002)
- Molecular and functional analysis of mouse decay accelerating factor (CD55). Harris, C.L., Rushmere, N.K., Morgan, B.P. Biochem. J. (1999)
- Alternative exon usage in the 3' region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor. Miwa, T., Okada, N., Okada, H. Immunogenetics (2000)
- Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia. Kaminski, H.J., Kusner, L.L., Richmonds, C., Medof, M.E., Lin, F. Exp. Neurol. (2006)